title: Feasibility and efficacy of administration of bortezomib-containing regimens to patients over the age of 70 years.
authors.forename: Christopher
authors.initials: C
authors.lastname: Parrish
authors.forename: Julian
authors.initials: J
authors.lastname: Cromack
authors.forename: Sylvia
authors.initials: S
authors.lastname: Feyler
authors.forename: John
authors.initials: J
authors.lastname: Ashcroft
authors.forename: Roger
authors.initials: R
authors.lastname: Owen
authors.forename: Gordon
authors.initials: G
authors.lastname: Cook
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001897:Boronic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D000069286:Bortezomib; D015331:Cohort Studies; D005260:Female; D006299:Health Services for the Aged; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000628:therapy*; D011719:Pyrazines / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib